Search This Blog

Wednesday, May 14, 2025

Your child’s ADHD could actually just be an undiagnosed vision issue

 Are we seeing the signs and symptoms of ADHD clearly?

A 2024 report from the Centers for Disease Control and Prevention revealed a staggering uptick in ADHD diagnoses among American children.

But many of these young patients could actually be suffering from an undiagnosed problem that can be detected with a more thorough vision test, Dr. Bryce Appelbaum, board-certified optometrist, tells The Post.

Functional vision is compromised when the eyes aren’t working together to support coordination or focus.Alexis S/peopleimages.com – stock.adobe.com

What is functional vision?

ADHD, or attention-deficit/hyperactivity disorder, is a developmental disorder characterized by inattentiveness, hyperactivity and impulsive behavior — but Appelbaum says that many of these symptoms are “identical” to ones for functional vision issues.

Functional vision is compromised when the eyes don’t work together to support coordination or focus. Essentially, “the muscles responsible for clarity are having a hard time turning on, staying turned on, or having flexibility,” Appelbaum said.

A common vision diagnosis that looks like ADD or ADHD-like behavior is convergence insufficiency, an eye coordination problem that makes it difficult for the eyes to focus on near objects, such as books or computer screens.

“A change in eye movement is a change in attention, whether voluntary or involuntary. If we can’t control our eye movements, we can’t control our attention,” he said.

How functional vision problems impact behavior

According to Appelbaum, people with convergence insufficiency are three times more likely to be diagnosed with ADHD. But standard eye tests fail to accurately measure functional vision, focusing instead on eyesight and eye health.

“A thorough functional vision exam goes beyond just the ability to see; it looks at that eye-brain connection,” he added.

“Somebody that can make their eyes point in the same direction — great. But then after 30 seconds, if they have this fragile coordination, that’s going to be a kid who has ants in their pants or is listening to the teacher with their ears rather than with their eyes,” Appelbaum said.

Dr. Bryce Appelbaum believes every child should have a functional vision test before kindergarten.Prostock-studio – stock.adobe.com
Appelbaum said missed or misdiagnosed vision problems can result in unnecessary struggles in the classroom and beyond. 

“Children can struggle with reading or navigating through space, or even with ball sports or social interaction, because the input from their eyes to their brain is scattered and not filtered appropriately,” he said.

What can be done about it?

Even though the eyes are the body’s dominant sensory system, two out of three children enter school without ever having a vision screening.

Appelbaum believes every child should have a thorough, comprehensive functional vision test before kindergarten to ensure they’re visually ready for learning and, eventually, reading.

Kids can literally go off medication after doing the right type of work… They can focus their eyes so they can focus their mind.

Bryce Appelbaum

Once a functional vision problem has been diagnosed, it can be treated and, in most cases, corrected with vision performance training.

“It’s like PT for the eyes, but really for the brain through the eyes,” he said. “With the right type of work, you can raise somebody’s awareness of what they’re doing so they can learn how to self-correct and self-monitor until the eyes and brain are working fluidly together as a team.”

Appelbaum said missed or misdiagnosed vision problems can result in unnecessary struggles in the classroom and beyond.linkedin/dr-bryce-appelbaum
Treating ADHD

One in nine children aged 3-17 is diagnosed with ADHD, but a 2021 study in JAMA Network Open reported “convincing evidence was found that ADHD is overdiagnosed in children and adolescents.”

For people with milder symptoms, “the harms associated with an ADHD diagnosis may often outweigh the benefits,” the researchers concluded.

ADHD is typically treated with a combination of behavior therapy and stimulant medication, the latter of which comes with a slew of side effects and drawbacks.

The array of stimulant medications used to treat the disorder — Vyvanse, Adderall, Concerta and Ritalin, to name a few — may be accompanied by adverse side effects.

ADHD is typically treated with a combination of behavior therapy and stimulant medication, the latter of which comes with a slew of side effects and drawbacks.David L/peopleimages.com – stock.adobe.com

Stimulants can cause appetite loss, difficulty sleeping, anxiety, changes in blood pressure and heart rate, and more. Drug misuse was also suggested among other “potential harms” noted by the CDC.

In 2022, the Drug Enforcement Agency issued a warning to manufacturers of ADHD drugs that it was concerned about “aggressive marketing practices” by companies — in particular, telehealth providers such as Cerebral — that could be driving excessive prescriptions.

Appelbaum believes children with behavioral issues rooted in vision problems can quickly and efficiently transition off these medications.

“Kids can literally go off medication after doing the right type of work because their eyes and brain are working together, and the need for stimulation is gone. They can focus their eyes so they can focus their mind,” he said.

For Appelbaum, the mission to educate parents about the relationship between vision and behavioral issues is a personal one. 

As a child, he struggled with focusing in the classroom and responding on the soccer field. His father, an optometrist, and mother, an occupational therapist, “put together a plan of action to help facilitate the development that was necessary for me to soar in life.” 

This plan included vision performance training. “This was 37 years ago. What took me years we can now accomplish in a matter of months based on innovations, new protocols. We see improvements rather quickly, especially when the brain has more opportunities for learning.” 

Appelbaum maintains that while vision testing and training can benefit children diagnosed with ADHD, the positive effects are available to adults as well.

“Any brain at any age can learn new tricks,” he said. “We need to put our vision first and look into the eye-brain connection, which goes beyond just going to the eye doctor and seeing if you need glasses. We must look at the functional visual skills because so much of our potential can be unlocked through vision.”

https://nypost.com/2025/05/14/health/could-your-childs-adhd-really-be-an-undiagnosed-vision-issue/

Trump meets Syria's Sharaa, urges for normalized ties

 U.S. President Donald Trump met with Syria's president in Saudi Arabia on Wednesday and said Washington was exploring the normalizing of ties with Damascus.

It comes after a surprise announcement the day before that the United States would lift all sanctions on the Islamist-led government.

Trump met Ahmed al-Sharaa in the presence of the Saudi Crown Prince Mohammed bin Salman

He said Turkish President Tayyip Erdogan also joined the meeting, virtually.

"We are currently exploring normalizing relations with Syria's new government, as you know. Beginning with my

meeting with President Ahmed al-Sharaa."

At a summit between the U.S. and Gulf Arab countries afterwards, Trump said he was lifting sanctions to give Syria the ability to make a fresh start, after decades of iron-fisted rule under former president Bashar al-Assad and his father.

"It gives them a chance for greatness. The sanctions were really crippling, very powerful."

According to the White House, the U.S. president also urged Sharaa to normalize ties with Syria's long-time enemy Israel.

The U.S.-brokered Abraham Accords saw the United Arab Emirates, Bahrain and Morocco normalize relations with Israel in 2020.

Trump said on Tuesday Saudi Arabia would join the accords in its own time.

Talks were halted after the Gaza war erupted, with the kingdom insisting there can be no normalization without Palestinian statehood.

U.S. ally Israel has opposed sanctions relief for Syria, but Trump on Tuesday said that MbS and Erdogan, who are both close to the U.S. president, had encouraged him to make the move.

Sharaa severed ties with al Qaeda in 2016, but Israeli officials have continued to call him a jihadist.

Israel's government did not immediately respond to requests for comment.

The decision is a major boost for Sharaa, who has been struggling to bring the country under control after toppling Assad in December.

https://www.yahoo.com/news/trump-meets-syrias-sharaa-urges-133246947.html

Merck & Co., Inc.: Citi downgrades to neutral from buy

 target price reduced from USD 115 to USD 84.

https://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/

Abbvie Inc.: Citi downgrades to neutral from buy

  target price reduced from USD 210 to USD 205.

https://www.marketscreener.com/quote/stock/ABBVIE-INC-12136589/

Trump's drug pricing order threatens Roche's $50 billion US investment plans, company says

 U.S. President Donald Trump’s recent executive order on drug pricing could potentially jeopardize Swiss pharmaceutical company Roche’s planned $50 billion investment in the United States. Roche, listed as ROG.S, expressed this concern on Wednesday.

The executive order, signed by President Trump on Monday, instructs pharmaceutical firms to reduce the prices of brand-name drugs to match those in other affluent countries. However, several analysts and legal professionals have voiced that implementing such a policy might pose significant challenges.

https://www.investing.com/news/stock-market-news/trumps-drug-pricing-order-threatens-roches-50b-us-investment-co-says-93CH-4045400

Nvidia, AMD Secure Saudi AI Data Center Deals During Trump's Gulf States Tour

 Several U.S. tech companies announced big AI deals in the Middle East after the White House announced the kingdom's commitment to invest $600 billion in the U.S.

Among the largest deals, Nvidia will supply 18,000 of its cutting-edge Blackwell chips to Humain, an AI startup just launched by Saudi Arabia's Public Investment Fund.

Tuesday's announcement comes as part of the White House's Gulf tour, which includes President Trump and top CEOs.

"I am so delighted to be here to help celebrate the grand opening, the beginning of Humain," CEO Jensen Huang told the audience at the Saudi-U.S. Investment Forum in Riyadh on Tuesday, adding, "It is an incredible vision, indeed, that Saudi Arabia should build the AI infrastructure of your nation so that you could participate and help shape the future of this incredibly transformative technology."

A New Chapter of Global Technological Leadership — Born in Riyadh!

Huang said that AI data centers are power-hungry, and the energy-rich country can use Nvidia's technology to unlock new capabilities. 

Humain plans to develop Arabic versions of large language models. CEO Tareq Amin said the startup would build 1.9 gigawatts of data centers by the decade's end. He anticipates Nvidia's technology will power AI factories across the Middle East. 

Here are the AI deals that were announced:

  • Nvidia will supply hundreds of thousands of AI chips to Saudi Arabia, starting with 18,000 Blackwell GPUs for Humain, a newly launched AI firm backed by Saudi Arabia's sovereign wealth fund.

  • AMD announced a $10 billion collaboration with Humain to deploy 500 megawatts of AI infrastructure, including CPUs, GPUs, and orchestration software.

  • Qualcomm signed an MoU with Humain to develop server CPUs for future data centers.

  • Saudi firm DataVolt will invest $20 billion in U.S. AI data centers and energy infrastructure.

  • Google, Oracle, Salesforce, AMD, Uber, and DataVolt will invest $80 billion into transformative technologies across both countries.

Trump's Gulf tour aims to ramp up trillions of investments between the U.S. and Saudi Arabia. 

Outside of chips, the White House announced a $142 billion defense deal with the kingdom to provide "state-of-the-art warfighting equipment and services from over a dozen U.S. defense firms." This is nearly double Saudi Arabia's 2025 defense budget. 

Tuesday's announcement highlights how Nvidia's chips have become a bargaining tool for the Trump administration. 

https://www.zerohedge.com/geopolitical/nvidia-amd-secure-saudi-ai-data-center-deals-during-trumps-gulf-states-tour

Eton 76% Revenue Growth and 17 Straight Quarters of Sales Gains

Eton Pharmaceuticals (NASDAQ: ETON) reported strong Q1 2025 financial results with revenue of $17.3 million, including product sales of $14.0 million - a 76% growth over Q1 2024. The company marked its 17th consecutive quarter of sequential product sales growth. Key highlights include: - Successful relaunch of INCRELEX for rare pediatric endocrinology condition - Out-licensed INCRELEX international rights to Esteve Pharmaceuticals for $4.3M upfront - Relaunched GALZIN for Wilson disease with Eton Cares support program - Submitted NDA for ET-600 following positive clinical study results - Preparing for potential ET-400 launch with PDUFA date of May 28th - Posted Q1 GAAP EPS of $(0.06) and Non-GAAP EPS of $0.07 - Generated $2.1M operating cash flow with $17.4M cash on hand The company expects to exit 2025 at approximately $80M annual revenue run rate.